Alimera Sciences, Inc. (ALIM)
NASDAQ: ALIM · IEX Real-Time Price · USD
5.57
-0.01 (-0.18%)
At close: Jul 19, 2024, 4:00 PM
5.62
+0.05 (0.90%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Alimera Sciences Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Alimera Sciences stock has a target of 6.00, which predicts an increase of 7.72% from the current stock price of 5.57.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for ALIM stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Alliance Global Partners | Alliance Global Partners | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jun 25, 2024 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jun 25, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $6 | Strong Buy → Hold | Downgrades | $6 | +7.72% | Jun 25, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +7.72% | May 16, 2024 |
| Maxim Group | Maxim Group | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +79.53% | Mar 25, 2024 |
Financial Forecast
Revenue This Year
108.41M
from 80.75M
Increased by 34.25%
Revenue Next Year
121.67M
from 108.41M
Increased by 12.23%
EPS This Year
-0.13
from -0.84
EPS Next Year
0.18
from -0.13
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 113.2M | 136.2M | 166.4M | 201.1M | 240.9M |
| Avg | 108.4M | 121.7M | 138.6M | 195.3M | 234.0M |
| Low | 103.4M | 110.0M | 119.0M | 187.7M | 224.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 40.1% | 25.6% | 36.8% | 45.0% | 23.3% |
| Avg | 34.2% | 12.2% | 13.9% | 40.9% | 19.8% |
| Low | 28.0% | 1.5% | -2.2% | 35.4% | 15.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.08 | 0.30 | 0.66 | 1.06 | 1.64 |
| Avg | -0.13 | 0.18 | 0.44 | 1.03 | 1.59 |
| Low | -0.17 | 0.07 | 0.23 | 0.99 | 1.53 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 260.3% | 141.8% | 59.0% |
| Avg | - | - | 138.9% | 134.9% | 54.5% |
| Low | - | - | 22.8% | 125.7% | 48.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.